IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Avidity Partners Management LP

Q2 2020 Holdings

Filed 2020-08-14 | 57 holdings | $385.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Ascendis Pharma A S(ASND)SPONSORED ADR04351P101$17.6M118,9004.6%
Coherus Biosciences Inc(CHRS)COM19249H103$18.3M1,023,5004.7%
Avantor Inc(AVTR)COM05352A100$27.4M1,612,0007.1%
Axsome Therapeutics Inc(AXSM)COM05464T104$33.3M404,9008.6%
Arvinas Inc(ARVN)COM04335A105$36.1M1,076,9009.4%
Aurinia Pharmaceuticals Inc(AUPH)COM05156V102$40.2M2,474,59910.4%
Abbvie Inc(ABBV)COM00287Y109$151.7M1,545,40039.4%
PreviousPage 2 of 2